These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 14988684)

  • 1. Combination therapy to treat moderate to severe psoriasis.
    Lebwohl M; Menter A; Koo J; Feldman SR
    J Am Acad Dermatol; 2004 Mar; 50(3):416-30. PubMed ID: 14988684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Topical corticosteroids and corticosteroid sparing therapy in psoriasis management].
    Sukarovska BG; Lipozencić J; Vrzogić P
    Acta Med Croatica; 2007 Sep; 61(4):375-81. PubMed ID: 18044472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined topical calcipotriene ointment 0.005% and various systemic therapies in the treatment of plaque-type psoriasis vulgaris: review of the literature and results of a survey sent to 100 dermatologists.
    Katz HI
    J Am Acad Dermatol; 1997 Sep; 37(3 Pt 2):S62-8. PubMed ID: 9344188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized comparison of acitretin-narrow-band TL-01 phototherapy and acitretin-psoralen plus ultraviolet A for psoriasis.
    Ozdemir M; Engin B; Baysal I; Mevlitoğlu I
    Acta Derm Venereol; 2008; 88(6):589-93. PubMed ID: 19002344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of treatment modalities for psoriasis.
    Tristani-Firouzi P; Krueger GG
    Cutis; 1998 Feb; 61(2 Suppl):11-21. PubMed ID: 9787987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic treatment for moderate to severe psoriasis: estimates of failure rates and direct medical costs in a north-eastern US managed care plan.
    Feldman SR; Evans C; Russell MW
    J Dermatolog Treat; 2005 Feb; 16(1):37-42. PubMed ID: 15897166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A clinician's paradigm in the treatment of psoriasis.
    Lebwohl M
    J Am Acad Dermatol; 2005 Jul; 53(1 Suppl 1):S59-69. PubMed ID: 15968265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Traditional therapies in the management of moderate to severe chronic plaque psoriasis: an assessment of the benefits and risks.
    Naldi L; Griffiths CE
    Br J Dermatol; 2005 Apr; 152(4):597-615. PubMed ID: 15840088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combining systemic retinoids with biologic agents for moderate to severe psoriasis.
    Smith EC; Riddle C; Menter MA; Lebwohl M
    Int J Dermatol; 2008 May; 47(5):514-8. PubMed ID: 18412874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combining etanercept with traditional agents in the treatment of psoriasis: a review of the clinical evidence.
    Foley PA; Quirk C; Sullivan JR; Dolianitis C; Hack SP; Thirunavukkarasu K; Cooper AJ
    J Eur Acad Dermatol Venereol; 2010 Oct; 24(10):1135-43. PubMed ID: 20337816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New roles for systemic retinoids.
    Lebwohl M; Kathryn M
    J Drugs Dermatol; 2006 May; 5(5):406-9. PubMed ID: 16703775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transition from methotrexate and cyclosporine to other therapies including retinoids, ultraviolet light and biologic agents in the management of patients with psoriasis.
    Maryles S; Rozenblit M; Lebwohl M
    J Dermatolog Treat; 2003; 14 Suppl 2():7-16. PubMed ID: 14578093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients with moderate-to-severe plaque psoriasis preferred oral therapies to phototherapies: a preference assessment based on clinical scenarios with trade-off questions.
    Opmeer BC; Heydendael VM; deBorgie CA; Spuls PI; Bossuyt PM; Bos JD; de Rie MA
    J Clin Epidemiol; 2007 Jul; 60(7):696-703. PubMed ID: 17573985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modifications of PUVA.
    Momtaz-T K; Fitzpatrick TB
    Dermatol Clin; 1995 Oct; 13(4):867-73. PubMed ID: 8785890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcitriol ointment: optimizing psoriasis therapy.
    Gold LF
    J Drugs Dermatol; 2009 Aug; 8(8 Suppl):s23-7. PubMed ID: 19702033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PUVA combination therapy.
    Morison WL
    Photodermatol; 1985 Aug; 2(4):229-36. PubMed ID: 3903677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic strategies: rotational therapy and combinations.
    van de Kerkhof PC
    Clin Exp Dermatol; 2001 Jun; 26(4):356-61. PubMed ID: 11422189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combining etanercept and acitretin in the therapy of chronic plaque psoriasis: a 24-week, randomized, controlled, investigator-blinded pilot trial.
    Gisondi P; Del Giglio M; Cotena C; Girolomoni G
    Br J Dermatol; 2008 Jun; 158(6):1345-9. PubMed ID: 18410408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cost-effectiveness and cost of treatment failures associated with systemic psoriasis therapies.
    Pearce DJ; Nelson AA; Fleischer AB; Balkrishnan R; Feldman SR
    J Dermatolog Treat; 2006; 17(1):29-37. PubMed ID: 16467021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term maintenance treatment of moderate-to-severe plaque psoriasis with infliximab in combination with methotrexate or azathioprine in a retrospective cohort.
    Dalaker M; Bonesrønning JH
    J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):277-82. PubMed ID: 19207642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.